{
    "eid": "2-s2.0-85075474315",
    "title": "Factors Affecting Generalization of Ocular Myasthenia Gravis in Patients With Positive Acetylcholine Receptor Antibody",
    "cover-date": "2020-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Ophthalmology",
            "@code": "2731",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [],
    "authors": [
        "Supanut Apinyawasisuk",
        "Yuda Chongpison",
        "Chawin Thitisaksakul",
        "Supharat Jariyakosol"
    ],
    "citedby-count": 16,
    "ref-count": 20,
    "ref-list": [
        "Ocular myasthenia gravis",
        "Ocular myasthenia gravis: toward a risk of generalization score and sample size calculation for a randomized controlled trial of disease modification",
        "Prognosis of ocular myasthenia in Korea: a retrospective multicenter analysis of 202 patients",
        "Factors affecting outcome in ocular myasthenia gravis",
        "Clinical predictors for the prognosis of myasthenia gravis",
        "Prognosis of ocular myasthenia",
        "Smoking and socio-economic status may affect myasthenia gravis",
        "Cigarette smoking and activities of daily living in ocular myasthenia gravis",
        "Generalization after ocular onset in myasthenia gravis: a case series in Germany",
        "Low conversion rate of ocular to generalized myasthenia gravis in Singapore",
        "Development of generalized disease at 2 years in patients with ocular myasthenia gravis",
        "Ocular myasthenia gravis: response to long-term immunosuppressive treatment",
        "Ocular presentation of myasthenia gravis: a natural history cohort",
        "Immunotherapy of ocular myasthenia gravis reduces conversion to generalized myasthenia gravis",
        "Smoking and risk of Graves\u2019 disease",
        "Thyroid eye disease and myasthenia gravis",
        "Nicotine-sensitive myasthenia gravis",
        "Inhibitors of acetylcholinesterase and butyrylcholinesterase meet immunity",
        "Serum high mobility group box 1 is upregulated in myasthenia gravis",
        "Cytokines and the pathogenesis of myasthenia gravis"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Emerging Infectious Disease Health Science Center",
        "King Chulalongkorn Memorial Hospital",
        "meet"
    ]
}